Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionvitamin transmembrane transporter activity

SLC2A6 ABCD4 SLC47A1 SLC2A3

2.84e-0636554GO:0090482
GeneOntologyMolecularFunctionorganic anion transmembrane transporter activity

SLC2A6 SLC10A6 ABCD4 LRRC8A SLC47A1 SLC2A3

1.50e-04293556GO:0008514
GeneOntologyMolecularFunctiondehydroascorbic acid transmembrane transporter activity

SLC2A6 SLC2A3

2.06e-048552GO:0033300
GeneOntologyMolecularFunctionfructose transmembrane transporter activity

SLC2A6 SLC2A3

2.65e-049552GO:0005353
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC5A5 SLC9C1 TMEM94 SLC2A6 ABCB8 SIDT1 SLC10A6 ABCD4 LRRC8A SLC47A1 SLC2A3

3.17e-0411805511GO:0022857
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC5A5 SLC9C1 TMEM94 ABCB8 SLC10A6 ABCD4 SLC47A1

3.20e-04477557GO:0022804
GeneOntologyMolecularFunctiontransporter activity

SLC5A5 SLC9C1 TMEM94 SLC2A6 ABCB8 SIDT1 SLC10A6 ABCD4 LRRC8A SLC47A1 SLC2A3

6.68e-0412895511GO:0005215
GeneOntologyMolecularFunctionATP hydrolysis activity

MDN1 MYO5B ABCB8 RSF1 ABCD4 POLQ

1.30e-03441556GO:0016887
GeneOntologyMolecularFunctionactive monoatomic ion transmembrane transporter activity

SLC5A5 SLC9C1 TMEM94 SLC10A6 SLC47A1

1.41e-03301555GO:0022853
GeneOntologyMolecularFunctionATP-dependent activity

MDN1 MYO5B TMEM94 ABCB8 RSF1 ABCD4 POLQ

1.42e-03614557GO:0140657
GeneOntologyMolecularFunctionD-glucose transmembrane transporter activity

SLC2A6 SLC2A3

2.15e-0325552GO:0055056
GeneOntologyMolecularFunctionhexose transmembrane transporter activity

SLC2A6 SLC2A3

2.15e-0325552GO:0015149
GeneOntologyMolecularFunctionmonosaccharide transmembrane transporter activity

SLC2A6 SLC2A3

2.50e-0327552GO:0015145
GeneOntologyMolecularFunctionsugar transmembrane transporter activity

SLC2A6 SLC2A3

2.88e-0329552GO:0051119
GeneOntologyMolecularFunctionATPase-coupled transmembrane transporter activity

TMEM94 ABCB8 ABCD4

3.38e-03109553GO:0042626
GeneOntologyBiologicalProcessvitamin transport

SLC2A6 ABCD4 SLC47A1 SLC2A3

1.50e-0556554GO:0051180
GeneOntologyCellularComponentATP-binding cassette (ABC) transporter complex

ABCB8 ABCD4

1.01e-046552GO:0043190
DomainVPS10

SORCS2 SORCS3

8.16e-055542SM00602
DomainSortilin_C

SORCS2 SORCS3

8.16e-055542PF15901
DomainSortilin-Vps10

SORCS2 SORCS3

8.16e-055542PF15902
DomainVPS10

SORCS2 SORCS3

8.16e-055542IPR006581
DomainSortilin_N

SORCS2 SORCS3

8.16e-055542IPR031778
DomainSortilin_C

SORCS2 SORCS3

8.16e-055542IPR031777
DomainVWFA

VWA3A MDN1 HMCN2 ITGAL

9.24e-0582544PS50234
DomainVWA

VWA3A MDN1 HMCN2 ITGAL

1.01e-0484544SM00327
DomainPKD

SORCS2 SORCS3

1.71e-047542PF00801
DomainVWF_A

VWA3A MDN1 HMCN2 ITGAL

1.92e-0499544IPR002035
DomainSialidases

SORCS2 SORCS3

2.92e-049542IPR011040
DomainPKD

SORCS2 SORCS3

4.44e-0411542PS50093
DomainPKD_dom

SORCS2 SORCS3

4.44e-0411542IPR000601
Domain-

SORCS2 SORCS3

4.44e-04115422.60.40.670
DomainSugar/inositol_transpt

SLC2A6 SLC2A3

7.30e-0414542IPR003663
DomainSUGAR_TRANSPORT_2

SLC2A6 SLC2A3

1.09e-0317542PS00217
DomainSUGAR_TRANSPORT_1

SLC2A6 SLC2A3

2.17e-0324542PS00216
DomainP-loop_NTPase

SAMD9L SAMD9 MDN1 MYO5B ABCB8 ABCD4 POLQ PAPSS2

2.85e-03848548IPR027417
DomainABC_TM1F

ABCB8 ABCD4

2.96e-0328542PS50929
DomainABC1_TM_dom

ABCB8 ABCD4

2.96e-0328542IPR011527
DomainSugar_transporter_CS

SLC2A6 SLC2A3

3.85e-0332542IPR005829
DomainMFS_sugar_transport-like

SLC2A6 SLC2A3

4.85e-0336542IPR005828
DomainSugar_tr

SLC2A6 SLC2A3

4.85e-0336542PF00083
Domain-

SAMD9L SAMD9 MDN1 ABCB8 ABCD4 POLQ PAPSS2

5.45e-037465473.40.50.300
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC5A5 MBTPS1 SLC9C1 LMF2 MYO5B SLC2A6 ABCB8 SLC10A6 LRRC8A SLC47A1 SLC2A3

3.43e-077363211M27287
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC5A5 LMF2 MYO5B SLC2A6 ABCB8 SLC10A6 LRRC8A SLC47A1 SLC2A3

1.40e-05681329MM14985
PathwayKEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II

GSTO1 SDHC

7.45e-056322M47810
PathwayREACTOME_VITAMIN_C_ASCORBATE_METABOLISM

GSTO1 SLC2A3

1.39e-048322M27091
PathwayREACTOME_VITAMIN_C_ASCORBATE_METABOLISM

GSTO1 SLC2A3

1.78e-049322MM14769
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC5A5 SLC2A6 SLC10A6 SLC47A1 SLC2A3

1.82e-04238325MM15076
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC5A5 SLC2A6 SLC10A6 SLC47A1 SLC2A3

2.25e-04249325M5988
PathwayWP_NUCLEAR_RECEPTORS_METAPATHWAY

SLC5A5 B3GNT5 SLC2A6 LRRC8A SLC2A3

6.52e-04314325M39428
PathwayREACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES

MBTPS1 LMF2

8.33e-0419322M27839
PathwayREACTOME_CELLULAR_HEXOSE_TRANSPORT

SLC2A6 SLC2A3

8.33e-0419322MM14718
PathwayREACTOME_CELLULAR_HEXOSE_TRANSPORT

SLC2A6 SLC2A3

1.02e-0321322M27058
PathwayWP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING

CD86 SLC2A3

1.12e-0322322M39345
Pubmed

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.

SAMD9L SAMD9

2.46e-06255234621053
Pubmed

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.

SAMD9L SAMD9

2.46e-06255233731850
Pubmed

Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes.

SAMD9L SAMD9

2.46e-06255230322869
Pubmed

[Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review].

SAMD9L SAMD9

2.46e-06255237357006
Pubmed

A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection.

SAMD9L SAMD9

2.46e-06255229447249
Pubmed

SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

SAMD9L SAMD9

2.46e-06255229535429
Pubmed

Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.

SAMD9L SAMD9

2.46e-06255217407603
Pubmed

Viral host range factors antagonize pathogenic SAMD9 and SAMD9L variants.

SAMD9L SAMD9

2.46e-06255236894052
Pubmed

PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L.

SAMD9L SAMD9

7.36e-06355237612499
Pubmed

Hidden Twins: SorCS Neuroreceptors Form Stable Dimers.

SORCS2 SORCS3

7.36e-06355228827148
Pubmed

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

SAMD9L SAMD9

7.36e-06355233038986
Pubmed

Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.

SAMD9L SAMD9

7.36e-06355232770553
Pubmed

Spatiotemporal expression analysis of the growth factor receptor SorCS3.

SORCS2 SORCS3

7.36e-06355224715575
Pubmed

The Role of CD40, CD86, and Glutathione S-Transferase Omega 1 in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

CD86 GSTO1

7.36e-06355236051533
Pubmed

The three sorCS genes are differentially expressed and regulated by synaptic activity.

SORCS2 SORCS3

7.36e-06355215009648
Pubmed

The genes for the human VPS10 domain-containing receptors are large and contain many small exons.

SORCS2 SORCS3

1.47e-05455211499680
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

VWA3A MDN1 INTS2 FANCI DPY30 CDS2 PHTF2 HACL1 USP37 SDHC

2.20e-051242551030973865
Pubmed

Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation.

SLC2A6 SLC2A3

5.13e-05755212554125
Pubmed

Defining the membrane proteome of NK cells.

LMF2 CSE1L MDN1 INTS2 FANCI CDS2 LRRC8A ECPAS ITGAL

8.34e-05116855919946888
Pubmed

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.

SLC2A6 SLC2A3

8.78e-05955219554504
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

KDM5B CSE1L INTS2 FANCI DPY30 RSF1

9.65e-0546955627634302
Pubmed

Mycobacterium tuberculosis infection of human dendritic cells decreases integrin expression, adhesion and migration to chemokines.

CD86 ITGAL

1.34e-041155223981064
Pubmed

The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins.

FANCI RSF1

1.34e-041155224800743
Pubmed

Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.

TCAIM INTS2 ECM2 PHTF2 RBM48 USP37 SACM1L

1.74e-0475055711230166
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

MDN1 INTS2 MYO5B FANCI CDS2 ECPAS FASTKD3

1.80e-0475455733060197
Pubmed

Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.

CSE1L CDS2 ECPAS

2.15e-047355323464991
Pubmed

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.

CSE1L MDN1 MYO5B PAPSS2 SACM1L

4.26e-0440055535013556
Pubmed

Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.

ABCB8 ABCD4

6.08e-042355210708515
Pubmed

Nutrient Transporter Gene Expression in the Early Conceptus-Implications From Two Mouse Models of Diabetic Pregnancy.

SLC2A6 SLC2A3

7.20e-042555235478964
Pubmed

Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.

SLC2A6 SLC2A3 SDHC

7.95e-0411455328245920
Pubmed

The LIFEdb database in 2006.

TCAIM INTS2 ECM2 PHTF2 USP37 SACM1L

9.44e-0472055616381901
Pubmed

From ORFeome to biology: a functional genomics pipeline.

TCAIM INTS2 ECM2 PHTF2 USP37 SACM1L

9.58e-0472255615489336
Pubmed

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.

CSE1L FANCI DPY30

1.04e-0312555321654808
Pubmed

Mitochondrial Fission Factor Is a Novel Interacting Protein of the Critical B Cell Survival Regulator TRAF3 in B Lymphocytes.

CDS2 GSTO1

1.04e-033055234745083
Pubmed

Characterizing embryonic gene expression patterns in the mouse using nonredundant sequence-based selection.

KDM5B SLC2A3

1.18e-033255214613977
Pubmed

Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing.

TCAIM INTS2 PHTF2 USP37 SACM1L

1.41e-0352355511256614
Pubmed

DNA cloning using in vitro site-specific recombination.

TCAIM INTS2 ECM2 PHTF2 USP37 SACM1L

1.56e-0379455611076863
InteractionP2RY8 interactions

INTS2 FANCI CDS2 ABCB8 ECPAS SACM1L

8.19e-06179546int:P2RY8
InteractionGPR45 interactions

CSE1L MDN1 INTS2 CDS2 ABCB8 ECPAS SACM1L

1.47e-05300547int:GPR45
InteractionVIPR1 interactions

CSE1L INTS2 CDS2 ABCB8 ECPAS SACM1L

1.77e-05205546int:VIPR1
InteractionHCST interactions

MDN1 INTS2 CDS2 LRRC8A ECPAS FASTKD3

1.77e-05205546int:HCST
InteractionGPR182 interactions

CSE1L MDN1 FANCI CDS2 ABCB8 ECPAS FASTKD3 SACM1L

2.66e-05455548int:GPR182
InteractionVSIG1 interactions

MDN1 INTS2 CDS2 ABCB8

4.14e-0572544int:VSIG1
InteractionCD80 interactions

INTS2 CD86 ABCB8 FASTKD3

5.96e-0579544int:CD80
InteractionVSIG4 interactions

FANCI CDS2 PTCD2 ECPAS SACM1L

1.19e-04180545int:VSIG4
InteractionSTS interactions

LMF2 ABCB8 LRRC8A

1.22e-0436543int:STS
InteractionCLEC2D interactions

FANCI CDS2 ABCB8 SLC47A1 FASTKD3

1.82e-04197545int:CLEC2D
Cytoband7q21.2

SAMD9L SAMD9 RBM48

7.33e-07155537q21.2
CytobandEnsembl 112 genes in cytogenetic band chr3q13

SLC9C1 CD86 SIDT1 POLQ

1.47e-04221554chr3q13
Cytoband3q13.2

SLC9C1 SIDT1

6.41e-04315523q13.2
CytobandEnsembl 112 genes in cytogenetic band chr7q21

SAMD9L SAMD9 RBM48

1.30e-03178553chr7q21
Cytoband9q34.11

HMCN2 LRRC8A

1.87e-03535529q34.11
GeneFamilySolute carriers

SLC5A5 SLC9C1 SLC2A6 SLC10A6 SLC47A1 SLC2A3

9.94e-05395356752
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC5A5 SAMD9 PTCD2 LRRC8A TANGO6

3.46e-06187555a6a112689d1c9049f57935ad9d2f4955538427de
ToppCellCOVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class

SLC2A6 CD86 PHTF2 ITGAL PAPSS2

4.13e-06194555d70b9039fd2fef3e4be086513b94fb7e9bc1f670
ToppCellCOVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class

SLC2A6 CD86 PHTF2 ITGAL PAPSS2

4.13e-061945555151546812678ae85cb22224084d27b29e3c4724
ToppCellPND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CD86 FANCI USP37 POLQ

4.03e-05155554b5d5c38b269e9318970fcce564df1c8ed7a7ccc6
ToppCellfacs-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TTC7A SLC2A6 ITGAL SLC2A3

5.26e-051665543195035445d35d820f5e00dd03b029730478b024
ToppCellfacs-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TTC7A SLC2A6 ITGAL SLC2A3

5.26e-051665546b6ecd70264b6bfbd8a3a378c965702829e2ecf1
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC2A6 SORCS3 ITGAL TANGO6

5.51e-05168554f45dbcd7753117a3e41e1412bce2100d52fa7fd0
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SAMD9 DGKK RBM48 ITGAL

5.77e-0517055428fb192b21cdc5a77ba4f276694cff852eb2304b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SAMD9 DGKK RBM48 ITGAL

5.77e-05170554239cb4b801b2d71a6facb386f2684c0851504151
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CD86 FANCI RNF175 POLQ

6.04e-05172554ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9

SAMD9 B3GNT5 SLC10A6 LRRC8A

6.46e-051755540cc215109d9915af47e4d0a120ce2e46910715fa
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MYO5B TMEM94 SORCS2 SLC2A3

6.46e-05175554bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L SAMD9 ECPAS ITGAL

6.75e-05177554d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SAMD9L SAMD9 ECPAS ITGAL

6.75e-05177554f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCellCOVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class

SAMD9L SAMD9 ECPAS ITGAL

6.75e-051775546978a22fef40c8b455342373abe7593f5ede0fa4
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

SAMD9L SAMD9 ECPAS ITGAL

6.75e-05177554936ab2b180a052387124f68d0c7f41c0b164e748
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SAMD9L SAMD9 ECPAS ITGAL

6.75e-05177554d5aeda113afaa2425874394610344570c9078478
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SERPINA11 CD86 SIDT1 ITGAL

7.05e-05179554716856b2c7c660bf5ce00e63efeda6ed121f2baa
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC2A6 CD86 SLC47A1 ITGAL

7.05e-05179554dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC2A6 CD86 SLC47A1 ITGAL

7.05e-05179554330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCellCOVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type

SAMD9 SIDT1 ITGAL SACM1L

7.36e-051815548906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

SAMD9L TCAIM PHTF2 SACM1L

8.18e-0518655476cbc3610aedf8c19c17ad5faf6ef5e8980b6af5
ToppCellDendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

B3GNT5 CD86 POLQ SLC2A3

8.18e-051865541d52912bd17e232cf39b2423a4d93585c164ba34
ToppCellBAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

B3GNT5 CD86 PAPSS2 GSTO1

9.43e-0519355493ba635ed69fec9286fe7636b9d258f3d93a22c3
ToppCellBAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

B3GNT5 CD86 PAPSS2 GSTO1

9.43e-051935546dfdeb793cb5ad6412b6f808b5687a4e74b6ec65
ToppCellnucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC2A6 CD86 PHTF2 ITGAL

9.62e-05194554e237384b02be460d44eeada3026a5691c66f6fc1
ToppCellBAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

B3GNT5 CD86 PAPSS2 GSTO1

9.62e-05194554e455cb469157c044126f9b0b308957d4ee1e608b
ToppCellnucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SLC2A6 CD86 PHTF2 ITGAL

9.62e-051945540bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC2A6 CD86 ITGAL PAPSS2

9.62e-0519455416c6fcbd36d473b883fb5361caca86eb134767ab
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CD86 SIDT1 ITGAL SLC2A3

9.62e-051945544dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCellBAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

B3GNT5 CD86 PAPSS2 GSTO1

9.62e-05194554e0cfd18a7ea2251163d61312b9397f8a518c8c51
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells)

CD86 FANCI RNF175 POLQ

9.82e-0519555447a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCellMild_COVID-19-Myeloid-MoAM3|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

B3GNT5 CD86 PAPSS2 GSTO1

1.00e-041965549faad17aa0b6af5a8ec2dadf7d70b9209d658072
ToppCellCOVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class

SLC2A6 CD86 ITGAL PAPSS2

1.00e-04196554af9e8f5ef9d03862f707e105857309b55595b1b9
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC2A6 CD86 PAPSS2 GSTO1

1.00e-041965547ce416e1809bfbb39553c28c20125790100a938d
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC2A6 CD86 PAPSS2 GSTO1

1.00e-0419655480264c2fbd94418f981085fed7c5bdda1e6f404c
ToppCell3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue

SLC2A6 CD86 RNF175 PAPSS2

1.00e-041965547fe97109a5a06b35fc081a85f341ea78da131323
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Macrophage|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC2A6 CD86 PAPSS2 GSTO1

1.00e-04196554292da8a0c052917a2f68afee9068b5b8e1544b13
ToppCellIPF-Epithelial|IPF / Disease state, Lineage and Cell class

VWA3A SLC9C1 CFAP54 MYO5B

1.00e-0419655487d9881cfec461a5d89b688a83749b618c519485
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LMF2 B3GNT5 FANCI POLQ

1.02e-04197554d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD86 PAPSS2 GSTO1 SLC2A3

1.02e-04197554367aaf277c56962c96ddb4de06949fb33fc6170b
ToppCellControl-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class

SAMD9L SIDT1 RNF175 ITGAL

1.04e-0419855476d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

B3GNT5 CD86 RNF175 POLQ

1.04e-041985542b724d2a36843801984d46a969d33149b76c9771
ToppCellControl_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

SAMD9 B3GNT5 SLC2A3 AGBL3

1.04e-041985543c3a5d2555f6af4aa33f9ea778808315d0e39d86
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD86 PAPSS2 GSTO1 SLC2A3

1.04e-0419855406e13ba14bda79e01a757ceb9e88de133053df61
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

B3GNT5 SLC2A6 CD86 SLC47A1

1.06e-0419955452c06fcc112da21b1d914a896c04bde06fc756fe
ToppCellBAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters

SAMD9L SAMD9 GSTO1 SLC2A3

1.06e-041995549f5750212b887f92761ade33fc6e108cd5275297
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SAMD9L SLC2A6 CD86 ITGAL

1.06e-04199554841338719d042247966867ac608146395eb8c4d9
ToppCellBronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SLC2A6 CD86 ITGAL PAPSS2

1.08e-04200554d39bf03817b76c9dfcbcd868341b51bb8601ea9b
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class

SAMD9L SAMD9 DGKK ITGAL

1.08e-042005542281debd86e5d92e8fe0397aec9ef670800f7471
DiseaseFamilial monosomy 7 syndrome

SAMD9L SAMD9

3.29e-062542cv:C5681220
DiseaseIntestinal Diseases

SAMD9 MYO5B

9.14e-058542C0021831
DiseaseInborn Errors of Metabolism

MYO5B ABCD4

4.39e-0417542C0025521
Diseaseintelligence, self reported educational attainment

SAMD9 CSE1L SORCS3

1.30e-03117543EFO_0004337, EFO_0004784
Diseaseattention function measurement

SORCS2 PHTF2 CSMD2

2.54e-03148543EFO_0007636
Diseaseidiopathic osteonecrosis of the femoral head

SAMD9 SORCS2

4.11e-0352542EFO_1001930
DiseaseMYELODYSPLASTIC SYNDROME

SAMD9 FANCI

6.74e-0367542C3463824
DiseaseBenign Neoplasm

SLC5A5 GSTO1

6.93e-0368542C0086692
DiseaseNeoplasms

SLC5A5 GSTO1

6.93e-0368542C0027651

Protein segments in the cluster

PeptideGeneStartEntry
GIVQTQEILQYLLPI

AGBL3

821

Q8NEM8
IYHNIVLVPVVQILI

CFAP54

1161

Q96N23
QVTPLLVYAQRQLLL

CFAP54

1781

Q96N23
LLLQVYQITGPVEIF

CSMD2

3331

Q7Z408
RLQEYNIPGVIQSVI

CDS2

311

O95674
LLEQFVIYQVGLIPS

ABCD4

51

O14678
IVPISNITENVYINL

CD86

141

P42081
INLESQYLLIQGVPA

RBM48

41

Q5RL73
YNLPIILLVVNNNGI

HACL1

471

Q9UJ83
IAYIPIQIGNLTNLE

LRRC8A

651

Q8IWT6
NLQEIPPLVYQLLVL

FANCI

206

Q9NVI1
VVELLQEQNIVPYTI

PAPSS2

206

O95340
LPNLQGIVVLNITSY

DGKK

926

Q5KSL6
LIQTAILIVQYLQRG

MDN1

2366

Q9NU22
VVENVPILGLYQIPA

MBTPS1

821

Q14703
LVPVLENSQGQLIYE

GSTO1

71

P78417
VLQYSVEVQVPPQLL

HMCN2

1706

Q8NDA2
NPVQIYIGLLQQLLA

ECPAS

651

Q5VYK3
QLLPLIDVYINSILT

INTS2

591

Q9H0H0
LQVSLPEIQELYQTL

KDM5B

1356

Q9UGL1
QQLTGITPILVYLQS

SLC2A6

286

Q9UGQ3
PNLIEYLQSLEQIGV

B3GNT5

201

Q9BYG0
LQGYQTQETVKPVIL

POLQ

1446

O75417
PQLYQSGVVVLVLTV

SDHC

146

Q99643
LVLLGNQIERIPGYV

ECM2

561

O94769
YRQPIIISIVLQLSQ

SLC2A3

266

P11169
YLDQTVVPILLQGLA

DPY30

56

Q9C005
LVYVGISIENIIPPQ

RSF1

971

Q96T23
VIIYGKQVIINLINQ

SACM1L

296

Q9NTJ5
VLLQALQILVYPGVG

PTCD2

16

Q8WV60
VNVQIPLLLGQLVEV

ABCB8

161

Q9NUT2
IIPSAIGNYIQIQLL

TAS2R16

141

Q9NYV7
NPLLYNITQVVILSA

PHTF2

751

Q8N3S3
LGGIQVVYIEELQPV

TCAIM

321

Q8N3R3
QILLISIPGFLVNYI

SLC9C1

106

Q4G0N8
YSQVLLQVLIIITGN

LMF2

256

Q9BU23
VQVIVYVTQLTLAPL

SORCS3

1101

Q9UPU3
IEVGLYTIQILQLTP

SAMD9L

1201

Q8IVG5
IEVGLYTIQILQLIP

SAMD9

1201

Q5K651
QRHLQLLGYQVVQIP

FASTKD3

616

Q14CZ7
LYLEVVPVIGLNQEV

SORCS2

876

Q96PQ0
IIPILYPINILIQDQ

ITGAL

916

P20701
KYLLNQGIVLPQIVT

SLC47A1

176

Q96FL8
IINLVAQVVPIYAVS

SLC47A1

371

Q96FL8
VEGNQNYPLLLLTLL

CSE1L

36

P55060
GIVIYAPALILNQVT

SLC5A5

146

Q92911
QYTLLQLQVNGVLPI

TMEM94

311

Q12767
YNLEDILPQIGLTNI

SERPINA11

321

Q86U17
QPVVIGIVQGIIYSL

RNF175

311

Q8N4F7
ALPVIQLVITYQTVV

SIDT1

456

Q9NXL6
ELLQFILQVQEVPYV

TRPC5OS

26

A6NMA1
VYQPLAVRELLILQG

TANGO6

266

Q9C0B7
QNLTIPYQNIGITLV

SLC10A6

156

Q3KNW5
NKIGQQVIIPRYLTL

USP37

576

Q86T82
DPQVILYVSLQLALV

TTC7A

531

Q9ULT0
GPYLQQVKTELVLLI

VWA3A

971

A6NCI4
IYQQLIKIAEGVLQP

MYO5B

1601

Q9ULV0